BeiGene
BGNE
#960
Rank
HK$157.29 B
Marketcap
HK$1,438
Share price
0.49%
Change (1 day)
15.11%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company